Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Actually Wings05 brings up an interesting change in the '09 PR wording.

Actually Wings05 brings up an interesting change in the '09 PR wording.

posted on Oct 05, 2009 03:32PM

TPL has announced 14 licenses in '09. For some of you that don't see the importance. It's another avenue to reach potential investors. TPL appears in our PR's, we should expect the same thing. We can't afford to miss the combination knockout. The following information was dropped from the Alliacense PR for the first time this year. It does beg the question, why? An oversight after transpiring for the last 14 times?

About the MMP Portfolio
The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting:
[email protected].

Replaced With:

About the MMP Portfolioâ„¢
The MMP Portfolio patents, filed by The TPL Group in the 1980s, include seven US patents as well as their European and Japanese counterparts, cover techniques that enable higher performance and lower cost designs essential to consumer and commercial digital systems ranging from PCs, cell phones and portable music players to communications infrastructure, medical equipment and automobiles.

Share
New Message
Please login to post a reply